These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 25605353)

  • 1. Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model.
    Lood R; Winer BY; Pelzek AJ; Diez-Martinez R; Thandar M; Euler CW; Schuch R; Fischetti VA
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1983-91. PubMed ID: 25605353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Engineered Peptides of a Phage Lysin as Effective Antimicrobials against Multidrug-Resistant Acinetobacter baumannii.
    Thandar M; Lood R; Winer BY; Deutsch DR; Euler CW; Fischetti VA
    Antimicrob Agents Chemother; 2016 May; 60(5):2671-9. PubMed ID: 26856847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of ARV-1502, a Proline-Rich Antimicrobial Peptide, in a Murine Model of Bacteremia Caused by Multi-Drug Resistant (MDR)
    Xiong YQ; Li L; Zhou Y; Kraus CN
    Molecules; 2019 Aug; 24(15):. PubMed ID: 31382389
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains.
    Li J; Nation RL; Owen RJ; Wong S; Spelman D; Franklin C
    Clin Infect Dis; 2007 Sep; 45(5):594-8. PubMed ID: 17682994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic efficacy of meropenem and rifampicin in a murine model of sepsis caused by multidrug-resistant Acinetobacter baumannii.
    Sun Y; Wang L; Li J; Zhao C; Zhao J; Liu M; Wang S; Lu C; Shang G; Jia Y; Wen A
    Eur J Pharmacol; 2014 Apr; 729():116-22. PubMed ID: 24561048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acinetobacter baumannii displays inverse relationship between meropenem resistance and biofilm production.
    Perez LR
    J Chemother; 2015 Feb; 27(1):13-6. PubMed ID: 24621167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing the Antimicrobial Activity of
    Fleeman R; Van Horn KS; Barber MM; Burda WN; Flanigan DL; Manetsch R; Shaw LN
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28289036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic effect of phages on extensively drug-resistant Acinetobacter baumannii-induced sepsis in mice].
    Deng LY; Yang ZC; Gong YL; Huang GT; Yin SP; Jiang B; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):523-8. PubMed ID: 27647067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper Resistance of the Emerging Pathogen Acinetobacter baumannii.
    Williams CL; Neu HM; Gilbreath JJ; Michel SL; Zurawski DV; Merrell DS
    Appl Environ Microbiol; 2016 Oct; 82(20):6174-6188. PubMed ID: 27520808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piscidin is highly active against carbapenem-resistant Acinetobacter baumannii and NDM-1-producing Klebsiella pneumonia in a systemic Septicaemia infection mouse model.
    Pan CY; Chen JC; Chen TL; Wu JL; Hui CF; Chen JY
    Mar Drugs; 2015 Apr; 13(4):2287-305. PubMed ID: 25874924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysine-Based Small Molecule Sensitizes Rifampicin and Tetracycline against Multidrug-Resistant
    Konai MM; Haldar J
    ACS Infect Dis; 2020 Jan; 6(1):91-99. PubMed ID: 31646866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surprising synergy of dual translation inhibition vs. Acinetobacter baumannii and other multidrug-resistant bacterial pathogens.
    Dillon N; Holland M; Tsunemoto H; Hancock B; Cornax I; Pogliano J; Sakoulas G; Nizet V
    EBioMedicine; 2019 Aug; 46():193-201. PubMed ID: 31353294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii.
    Schafer JJ; Goff DA; Stevenson KB; Mangino JE
    Pharmacotherapy; 2007 Jul; 27(7):980-7. PubMed ID: 17594203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Episinuleptolide Decreases the Expression of the Extracellular Matrix in Early Biofilm Formation of Multi-Drug Resistant Acinetobacter baumannii.
    Tseng SP; Hung WC; Huang CY; Lin YS; Chan MY; Lu PL; Lin L; Sheu JH
    Mar Drugs; 2016 Jul; 14(8):. PubMed ID: 27483290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of sulbactam and its combination with imipenem, colistin and tigecycline in an experimental model of carbapenem-resistant Acinetobacter baumannii sepsis.
    Dinc G; Demiraslan H; Elmali F; Ahmed SS; Metan G; Alp E; Doganay M
    Chemotherapy; 2013; 59(5):325-9. PubMed ID: 24525528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ability of bacteriophage in resolving wound infection caused by multidrug-resistant Acinetobacter baumannii in uncontrolled diabetic rats.
    Shivaswamy VC; Kalasuramath SB; Sadanand CK; Basavaraju AK; Ginnavaram V; Bille S; Ukken SS; Pushparaj UN
    Microb Drug Resist; 2015 Apr; 21(2):171-7. PubMed ID: 25411824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and bioevaluation of SRI-12742 as an antimicrobial agent against multidrug-resistant Acinetobacter baumannii.
    Shukla M; Soni I; Matsuyama K; Tran T; Tanga M; Gong L; Chopra S
    Int J Antimicrob Agents; 2018 Jul; 52(1):22-27. PubMed ID: 29501820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of secondary metabolite of Actinidia deliciosa on the biofilm and extra-cellular matrix components of Acinetobacter baumannii.
    Tiwari V; Tiwari D; Patel V; Tiwari M
    Microb Pathog; 2017 Sep; 110():345-351. PubMed ID: 28705748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical isolates of Acinetobacter baumannii from a Portuguese hospital: PFGE characterization, antibiotic susceptibility and biofilm-forming ability.
    Duarte A; Ferreira S; Almeida S; Domingues FC
    Comp Immunol Microbiol Infect Dis; 2016 Apr; 45():29-33. PubMed ID: 27012918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.